vanadates has been researched along with 15-deoxy-delta(12,14)-prostaglandin j2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, YH; Chen, CW; Lin, WW; Tsi, CJ | 1 |
1 other study(ies) available for vanadates and 15-deoxy-delta(12,14)-prostaglandin j2
Article | Year |
---|---|
Inhibition of IFN-gamma-mediated inducible nitric oxide synthase induction by the peroxisome proliferator-activated receptor gamma agonist, 15-deoxy-delta 12,14-prostaglandin J2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway.
Topics: Acetylcysteine; Animals; Antioxidants; Cell Line; DNA-Binding Proteins; Down-Regulation; Enzyme Induction; Glutathione; HT29 Cells; Humans; Interferon Regulatory Factor-1; Interferon-gamma; Interleukin-6; Janus Kinase 2; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxisomes; Phosphoproteins; Phosphorylation; Prostaglandin D2; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tyrosine; Vanadates | 2003 |